SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech News
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tnsaf who started this subject3/28/2001 4:11:26 AM
From: sim1  Read Replies (1) of 7143
 
Artificial Thymus [Technology Review]

Laboratory production of T cells—immune cells that grow
naturally in the thymus gland—could provide new
therapies against cancer, autoimmune disorders and organ
transplant rejection. But they're hard to grow in culture
dishes; current methods yield too few cells of too little
variety. Researchers from Massachusetts General Hospital
in Boston and the Woburn, MA, biotechnology firm Cell
Science Therapeutics have developed an artificial thymus
that solves both problems. Constructed from a porous
metal-and-carbon material typically used for bone repair
and arranged in a three-dimensional matrix, the structure
mimics the functions of a living-tissue thymus, generating
a bumper crop of T cells that can adjust to new threats.
Clinical trials start in 2002, with commercial availability
expected a few years later. —M. Wortman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News